Company profile
Planet 13 Holdings Inc.
OTC: PLNH · Healthcare · Drug Manufacturers - Specialty & Generic
#347 of 1,422 Healthcare companies by revenue31st-percentile growth
EA Score
45DFH 47DQ 35GM 50SS 60
v0.1 · 65/100 weight · provisional
↑ workforce scale, growth stability · ↓ disclosure history, return on equity
Methodology →Revenue TTM
$96.4M
Rev growth YoY (TTM)
-20.7%
Net income (FY)
-$63.9M
Employees
724
as of 2026-08-20
Market cap
$48.3M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$103.4M$103.4M2025
Net income-$63.9M-$63.9M2025
Total assets$152.3M$152.3M2025
Liabilities$101.2M$101.2M2025
Equity$51.1M$51.1M2025
Revenue trend
FY2022 – FY2025 · USD
FY22
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Retail90%
Wholesale10%
By geography
Not disclosed.
The read
What is Planet 13 Holdings Inc.’s revenue?
Planet 13 Holdings Inc. booked $103.4M in FY2025 revenue, contracting 11% year over year — slower than 69% of Healthcare companies we track, at a -61.8% net margin.
Peers · Healthcare
Zevra Therapeutics, Inc.70BZymeworks Inc.55COwlet, Inc.49DSanara MedTech Inc.61CSutro Biopharma, Inc.47DViewRay, Inc.——Neighbors
Clark →Key facts
CEORobert Allen Groesbeck
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersLas Vegas, NV
ExchangeOTC: PLNH
Employees724
IPO date2018-07-12
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.